OPEN END TURBO SHORT - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME8PC78

Market Closed - Börse Stuttgart 01:16:22 22/05/2024 am IST
3.72 EUR +5.68% Intraday chart for OPEN END TURBO SHORT - BECTON DICKINSON AND CO.
Current month-2.11%
1 month-4.12%
Date Price Change
21/24/21 3.72 +5.68%
20/24/20 3.52 -2.22%
17/24/17 3.6 +2.27%
16/24/16 3.52 +0.86%
15/24/15 3.49 -5.93%

Delayed Quote Börse Stuttgart

Last update May 22, 2024 at 01:16 am IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME8PC7
ISINDE000ME8PC78
Date issued 13/02/2024
Strike 274.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.98
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.15
Lowest since issue 2.52

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
234.9 USD
Average target price
279 USD
Spread / Average Target
+18.79%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW